Cutia Therapeutics Income Statement - Cutia Therapeutics - Alpha Spread
C

Cutia Therapeutics
HKEX:2487

Watchlist Manager
Cutia Therapeutics
HKEX:2487
Watchlist
Price: 14.06 HKD -0.28% Market Closed
Market Cap: 4.3B HKD
Have any thoughts about
Cutia Therapeutics?
Write Note

Income Statement

Earnings Waterfall
Cutia Therapeutics

Revenue
198.9m CNY
Cost of Revenue
-98.8m CNY
Gross Profit
100.1m CNY
Operating Expenses
-627m CNY
Operating Income
-526.9m CNY
Other Expenses
2.6m CNY
Net Income
-524.3m CNY

Income Statement
Cutia Therapeutics

Rotate your device to view
Income Statement
Currency: CNY
Dec-2023 Jun-2024
Revenue
Revenue
138
N/A
199
+44%
Gross Profit
Cost of Revenue
(67)
(99)
Gross Profit
71
N/A
100
+41%
Operating Income
Operating Expenses
(2 052)
(627)
Selling, General & Administrative
(377)
(403)
Research & Development
(193)
(202)
Depreciation & Amortization
(41)
(39)
Other Operating Expenses
(1 441)
18
Operating Income
(1 981)
N/A
(527)
+73%
Pre-Tax Income
Interest Income Expense
42
4
Non-Reccuring Items
(25)
(2)
Pre-Tax Income
(1 964)
N/A
(524)
+73%
Net Income
Tax Provision
0
0
Income from Continuing Operations
(1 964)
(524)
Net Income (Common)
(1 964)
N/A
(524)
+73%
EPS (Diluted)
-6.46
N/A
-1.72
+73%

See Also

Discover More